Title f-27 LAWS reference
Explore the full hierarchy of this title across chapters, subchapters, and parts.
Select a part from the tree to begin
Browse chapters and parts on the left to load sections
CANADA • Title f-27 Laws • Part 3.3
Part 3.3 — Duty to publicize clinical trial information
This section mandates that entities holding a specific authorization must publicly disclose prescribed clinical trial information within defined timeframes and according to specified procedures.
What this part covers
- The holder of an authorization referred to in section 3.1 shall ensure that prescribed information concerning the clinical trial is made public.
- The holder of an authorization referred to in section 3.1 shall ensure that prescribed information concerning the clinical trial is made public within the prescribed time.
- The holder of an authorization referred to in section 3.1 shall ensure that prescribed information concerning the clinical trial is made public in the prescribed manner.
Sections in Part 3.3
Regulatory Context
This document sits within CANADA Laws and is most useful when linked to operational submission, quality, and inspection workflows.
CANADALaws